
Eli Lilly’s Mounjaro overtakes Merck’s Keytruda as world’s top-selling drug
Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s best-selling medication.Mounjaro generated $8.7 billion for




